Vale Dr Harald Breidahl 30 January 2018 Dr Harald (Hal) Breidahl passed away recently. Dr Breidahl was a towering figure in the Australian diabetes movement and worked tirelessly as an endocrinologist and as a researcher. His commitment to supporting people with diabetes led him to call for a national diabetes organisation in the 1950’s. That vision became a reality with the formation of the Diabetes Federation of Australia (now Diabetes Australia) in 1957, giving people with diabetes, health professionals and researchers one body to unite behind and to achieve real change. He became president of the national body in 1977 – and worked with consumers and health experts across the nation to steer the country towards a better future for people with diabetes. Dr Breidahl was part of an Australian delegation to help establish the International Diabetes Federation in 1952. Later he worked on attracting the first World Diabetes Congress to Australia, held in Sydney in 1988. He also played a pivotal role in the formation of the Australian Diabetes Society, the organisation that represents medical specialists, doctors and scientists, and served as the Society’s first President. His passion, energy and good humour has helped improve the quality of life for all Australians with diabetes. Dr Breidahl we thank you and salute you.
News 29 July 2026 Records tumble as Kennedy takes silver Diabetes has proven no barrier for Blue Circle Collective Ambassador Lachie Kennedy as he became the fastest man in Australian history at the Commonwealth Games in Birmingham overnight (Australian time). Continue Reading
Blog 27 July 2026 Round up for Diabetes Australia and turn small change into impact Learn how your spare change with Round up goes straight to Diabetes Australia to support programs, research, education, and advocacy. Continue Reading
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading